Cargando…

Longitudinal Analysis of the Costs Associated with Inpatient Initiation and Subsequent Outpatient Continuation of Proton Pump Inhibitor Therapy for Stress Ulcer Prophylaxis in a Large Managed Care Organization

BACKGROUND: Proton pump inhibitor (PPI) therapy is commonly initiated in hospitals for a variety of reasons including stress ulcer prophylaxis. Outpatient use of inpatient-initiated PPI use may be medically unwarranted. OBJECTIVES: To (a) describe in a longitudinal analysis the incidence and reasons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Lisa, Culley, Eric J., Gladowski, Patricia, Goff, Vickie, Fong, John, Marche, Sarah M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437701/ https://www.ncbi.nlm.nih.gov/pubmed/20178397 http://dx.doi.org/10.18553/jmcp.2010.16.2.122

Ejemplares similares

Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review
por: Shin, Sooyoung
Publicado: (2015)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Song, Myung Jin, et al.
Publicado: (2021)

Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
por: Ro, Youngouk, et al.
Publicado: (2016)

Reducing Inappropriate Proton Pump Inhibitors Use for Stress Ulcer Prophylaxis in Hospitalized Patients: Systematic Review of De-Implementation Studies
por: Orelio, Claudia C., et al.
Publicado: (2021)

Is it possible to use Proton Pump Inhibitors in COVID-19 treatment and prophylaxis?
por: Taştemur, Şeyma, et al.
Publicado: (2020)

Proton pump inhibitors versus histamine-2 receptor blockers for stress ulcer prophylaxis in patients with sepsis: a retrospective cohort study
por: Huang, Minqiang, et al.
Publicado: (2021)

Initiation of Continuous rhPTH Infusion With Insulin Pump in an Inpatient Setting
por: Lindsay Mart, Faith, et al.
Publicado: (2023)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Effects of proton pump inhibitor versus H2-receptor antagonist stress ulcer prophylaxis on ventilator-associated pneumonia: a pilot study
por: Fogas, JF, et al.
Publicado: (2013)

Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials
por: Alshamsi, Fayez, et al.
Publicado: (2016)

Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist?
por: Eun, Chang Soo
Publicado: (2017)

Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort study
por: Hsieh, Hui-Hsia, et al.
Publicado: (2021)

Educational Intervention Improves Proton Pump Inhibitor Stewardship in Outpatient Gastroenterology Clinics
por: Walker, Megan J., et al.
Publicado: (2019)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis
por: Kondo, Yutaka, et al.
Publicado: (2020)

CYP2C19 Gene Profiling as a Tool for Personalized Stress Ulcer Prophylaxis With Proton Pump Inhibitors in Critically Ill Patients - Recommendations Proposal
por: Bořilová Linhartová, Petra, et al.
Publicado: (2022)

High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
por: Hsieh, Yu-Hsi, et al.
Publicado: (2013)

Effect of a Proton Pump Inhibitor on the Duodenum Microbiome of Gastric Ulcer Patients
por: Lim, Jung-Hyun, et al.
Publicado: (2022)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

The associations of continuity of care with inpatient, outpatient, and total medical care costs among older adults with urinary incontinence
por: Han, Eunkyung, et al.
Publicado: (2023)

Measuring inpatient and outpatient costs: A cost-function approach
por: Carey, Kathleen, et al.
Publicado: (1992)

Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial
por: Krag, Mette, et al.
Publicado: (2016)

Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy
por: Steinke, Sabine I. B., et al.
Publicado: (2013)

Diagnostic accuracy of existing methods for identifying diabetic foot ulcers from inpatient and outpatient datasets
por: Sohn, Min-Woong, et al.
Publicado: (2010)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Selective Targeting of Virus Replication by Proton Pump Inhibitors
por: Watanabe, Susan M., et al.
Publicado: (2020)

Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis
por: Zhou, Xiaoyang, et al.
Publicado: (2019)

Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study
por: Haroon, Muhammad, et al.
Publicado: (2013)

An Overview of Outpatient and Inpatient Detoxification
por: Hayashida, Motoi
Publicado: (1998)

Correction: Cost-of-Illness in Psoriasis: Comparing Inpatient and Outpatient Therapy
por: Steinke, Sabine, et al.
Publicado: (2014)

Cost Comparison of Outpatient Versus Inpatient Unicompartmental Knee Arthroplasty
por: Richter, Dustin L., et al.
Publicado: (2017)

Resolution of Fundic Gland Polyposis following Laparoscopic Magnetic Sphincter Augmentation and Subsequent Cessation of Proton Pump Inhibitors
por: Brockmeyer, Joel R., et al.
Publicado: (2015)

Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: a systematic review and meta-analysis
por: Nishizawa, Toshihiro, et al.
Publicado: (2015)

High-Dose Proton Pump Inhibitors Are Superior to Standard-Dose Proton Pump Inhibitors in High-Risk Patients With Bleeding Ulcers and High-Risk Stigmata After Endoscopic Hemostasis
por: Zhu, Zhenhua, et al.
Publicado: (2021)

Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs
por: Lee, Junsoo, et al.
Publicado: (2021)

Survey of stress ulcer prophylaxis
por: Erstad, Brian L, et al.
Publicado: (1999)

Cost analysis of UMMC services: estimating the unit cost for outpatient and inpatient services
por: Dahlui, Maznah, et al.
Publicado: (2012)

Experience of stigmatization in children receiving inpatient and outpatient mental health treatment: a longitudinal study
por: Kaushik, Anya, et al.
Publicado: (2021)

Continuous absorption pumping
por: Liburg, M Yu
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_rpnor9rfrv8gofdoev215vic8q